$TMDX News

TransMedics Group, Inc. (TMDX) Presents at Canaccord Genuity's 46th Annual Growth Conference - Slideshow

TransMedics: Margins Down, Concentration Up, Trials Delayed

UBS Maintains Neutral on TransMedics Group, Lowers Price Target to $77

Piper Sandler Reiterates Overweight on TransMedics Group, Lowers Price Target to $100

TransMedics Group, Inc. 2026 Q2 - Results - Earnings Call Presentation

TransMedics Group (NASDAQ:TMDX) Falls as Q2 Earnings Miss Offsets Inline Revenue

TransMedics Group, Inc. (TMDX) Q2 2026 Earnings Call Transcript

TransMedics Group Raises FY2026 Sales Guidance from $727.000M-$757.000M to $737.000M-$757.000M vs $732.700M Est

TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate

Needham Maintains Buy on TransMedics Group, Lowers Price Target to $106

TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum

Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $90

TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target

TransMedics: The Margins Must Recover

TransMedics Group (NASDAQ:TMDX) Screens as an Affordable Growth Stock with Strong Momentum

Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80

TransMedics: Why I'm Still Bullish After The Collapse

TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals

TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow

Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $75